1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Mycalolide B by Type
  • 1.3.1 Overview: Global Mycalolide B Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global Mycalolide B Consumption Value Market Share by Type in 2025
  • 1.3.3 ≥95% HPLC Grade
  • 1.3.4 ≥98% HPLC Grade
  • 1.3.5 NMR-Confirmed High-Purity Grade
• 1.4 Classification of Mycalolide B by Package Size
  • 1.4.1 Overview: Global Mycalolide B Market Size by Package Size: 2021 Versus 2025 Versus 2032
  • 1.4.2 Global Mycalolide B Consumption Value Market Share by Package Size in 2025
  • 1.4.3 20 µg Vial
  • 1.4.4 100 µg Vial
  • 1.4.5 Custom Micro-Scale Package
• 1.5 Classification of Mycalolide B by Delivery Form
  • 1.5.1 Overview: Global Mycalolide B Market Size by Delivery Form: 2021 Versus 2025 Versus 2032
  • 1.5.2 Global Mycalolide B Consumption Value Market Share by Delivery Form in 2025
  • 1.5.3 Lyophilized Solid
  • 1.5.4 Lyophilized Wax
  • 1.5.5 Clear-to-White Solid
• 1.6 Global Mycalolide B Market by Application
  • 1.6.1 Overview: Global Mycalolide B Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Medical Care
  • 1.6.3 Research
  • 1.6.4 Others
• 1.7 Global Mycalolide B Market Size & Forecast
• 1.8 Global Mycalolide B Market Size and Forecast by Region
  • 1.8.1 Global Mycalolide B Market Size by Region: 2021 VS 2025 VS 2032
  • 1.8.2 Global Mycalolide B Market Size by Region, (2021-2032)
  • 1.8.3 North America Mycalolide B Market Size and Prospect (2021-2032)
  • 1.8.4 Europe Mycalolide B Market Size and Prospect (2021-2032)
  • 1.8.5 Asia-Pacific Mycalolide B Market Size and Prospect (2021-2032)
  • 1.8.6 South America Mycalolide B Market Size and Prospect (2021-2032)
  • 1.8.7 Middle East & Africa Mycalolide B Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 FUJIFILM Wako Pure Chemical
  • 2.1.1 FUJIFILM Wako Pure Chemical Details
  • 2.1.2 FUJIFILM Wako Pure Chemical Major Business
  • 2.1.3 FUJIFILM Wako Pure Chemical Mycalolide B Product and Solutions
  • 2.1.4 FUJIFILM Wako Pure Chemical Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 FUJIFILM Wako Pure Chemical Recent Developments and Future Plans
• 2.2 Enzo Life Sciences
  • 2.2.1 Enzo Life Sciences Details
  • 2.2.2 Enzo Life Sciences Major Business
  • 2.2.3 Enzo Life Sciences Mycalolide B Product and Solutions
  • 2.2.4 Enzo Life Sciences Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Enzo Life Sciences Recent Developments and Future Plans
• 2.3 Santa Cruz Biotechnology
  • 2.3.1 Santa Cruz Biotechnology Details
  • 2.3.2 Santa Cruz Biotechnology Major Business
  • 2.3.3 Santa Cruz Biotechnology Mycalolide B Product and Solutions
  • 2.3.4 Santa Cruz Biotechnology Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Santa Cruz Biotechnology Recent Developments and Future Plans
• 2.4 Focus Biomolecules
  • 2.4.1 Focus Biomolecules Details
  • 2.4.2 Focus Biomolecules Major Business
  • 2.4.3 Focus Biomolecules Mycalolide B Product and Solutions
  • 2.4.4 Focus Biomolecules Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Focus Biomolecules Recent Developments and Future Plans
• 2.5 Biorbyt
  • 2.5.1 Biorbyt Details
  • 2.5.2 Biorbyt Major Business
  • 2.5.3 Biorbyt Mycalolide B Product and Solutions
  • 2.5.4 Biorbyt Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Biorbyt Recent Developments and Future Plans
• 2.6 AG Scientific
  • 2.6.1 AG Scientific Details
  • 2.6.2 AG Scientific Major Business
  • 2.6.3 AG Scientific Mycalolide B Product and Solutions
  • 2.6.4 AG Scientific Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 AG Scientific Recent Developments and Future Plans
• 2.7 Abbexa
  • 2.7.1 Abbexa Details
  • 2.7.2 Abbexa Major Business
  • 2.7.3 Abbexa Mycalolide B Product and Solutions
  • 2.7.4 Abbexa Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 Abbexa Recent Developments and Future Plans
• 2.8 GLP Bio
  • 2.8.1 GLP Bio Details
  • 2.8.2 GLP Bio Major Business
  • 2.8.3 GLP Bio Mycalolide B Product and Solutions
  • 2.8.4 GLP Bio Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 GLP Bio Recent Developments and Future Plans
• 2.9 Aladdin Scientific
  • 2.9.1 Aladdin Scientific Details
  • 2.9.2 Aladdin Scientific Major Business
  • 2.9.3 Aladdin Scientific Mycalolide B Product and Solutions
  • 2.9.4 Aladdin Scientific Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Aladdin Scientific Recent Developments and Future Plans
• 2.10 BOC Sciences
  • 2.10.1 BOC Sciences Details
  • 2.10.2 BOC Sciences Major Business
  • 2.10.3 BOC Sciences Mycalolide B Product and Solutions
  • 2.10.4 BOC Sciences Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 BOC Sciences Recent Developments and Future Plans
• 2.11 Alfa Chemistry
  • 2.11.1 Alfa Chemistry Details
  • 2.11.2 Alfa Chemistry Major Business
  • 2.11.3 Alfa Chemistry Mycalolide B Product and Solutions
  • 2.11.4 Alfa Chemistry Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 Alfa Chemistry Recent Developments and Future Plans
• 2.12 G-Biosciences
  • 2.12.1 G-Biosciences Details
  • 2.12.2 G-Biosciences Major Business
  • 2.12.3 G-Biosciences Mycalolide B Product and Solutions
  • 2.12.4 G-Biosciences Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 G-Biosciences Recent Developments and Future Plans
• 2.13 Tribioscience
  • 2.13.1 Tribioscience Details
  • 2.13.2 Tribioscience Major Business
  • 2.13.3 Tribioscience Mycalolide B Product and Solutions
  • 2.13.4 Tribioscience Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Tribioscience Recent Developments and Future Plans
• 2.14 TargetMol
  • 2.14.1 TargetMol Details
  • 2.14.2 TargetMol Major Business
  • 2.14.3 TargetMol Mycalolide B Product and Solutions
  • 2.14.4 TargetMol Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 TargetMol Recent Developments and Future Plans
• 2.15 InvivoChem
  • 2.15.1 InvivoChem Details
  • 2.15.2 InvivoChem Major Business
  • 2.15.3 InvivoChem Mycalolide B Product and Solutions
  • 2.15.4 InvivoChem Mycalolide B Revenue, Gross Margin and Market Share (2021-2026)
  • 2.15.5 InvivoChem Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Mycalolide B Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of Mycalolide B by Company Revenue
  • 3.2.2 Top 3 Mycalolide B Players Market Share in 2025
  • 3.2.3 Top 6 Mycalolide B Players Market Share in 2025
• 3.3 Mycalolide B Market: Overall Company Footprint Analysis
  • 3.3.1 Mycalolide B Market: Region Footprint
  • 3.3.2 Mycalolide B Market: Company Product Type Footprint
  • 3.3.3 Mycalolide B Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Mycalolide B Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global Mycalolide B Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global Mycalolide B Consumption Value Market Share by Application (2021-2026)
• 5.2 Global Mycalolide B Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America Mycalolide B Consumption Value by Type (2021-2032)
• 6.2 North America Mycalolide B Market Size by Application (2021-2032)
• 6.3 North America Mycalolide B Market Size by Country
  • 6.3.1 North America Mycalolide B Consumption Value by Country (2021-2032)
  • 6.3.2 United States Mycalolide B Market Size and Forecast (2021-2032)
  • 6.3.3 Canada Mycalolide B Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico Mycalolide B Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe Mycalolide B Consumption Value by Type (2021-2032)
• 7.2 Europe Mycalolide B Consumption Value by Application (2021-2032)
• 7.3 Europe Mycalolide B Market Size by Country
  • 7.3.1 Europe Mycalolide B Consumption Value by Country (2021-2032)
  • 7.3.2 Germany Mycalolide B Market Size and Forecast (2021-2032)
  • 7.3.3 France Mycalolide B Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom Mycalolide B Market Size and Forecast (2021-2032)
  • 7.3.5 Russia Mycalolide B Market Size and Forecast (2021-2032)
  • 7.3.6 Italy Mycalolide B Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific Mycalolide B Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific Mycalolide B Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific Mycalolide B Market Size by Region
  • 8.3.1 Asia-Pacific Mycalolide B Consumption Value by Region (2021-2032)
  • 8.3.2 China Mycalolide B Market Size and Forecast (2021-2032)
  • 8.3.3 Japan Mycalolide B Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea Mycalolide B Market Size and Forecast (2021-2032)
  • 8.3.5 India Mycalolide B Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia Mycalolide B Market Size and Forecast (2021-2032)
  • 8.3.7 Australia Mycalolide B Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America Mycalolide B Consumption Value by Type (2021-2032)
• 9.2 South America Mycalolide B Consumption Value by Application (2021-2032)
• 9.3 South America Mycalolide B Market Size by Country
  • 9.3.1 South America Mycalolide B Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil Mycalolide B Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina Mycalolide B Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa Mycalolide B Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa Mycalolide B Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa Mycalolide B Market Size by Country
  • 10.3.1 Middle East & Africa Mycalolide B Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey Mycalolide B Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia Mycalolide B Market Size and Forecast (2021-2032)
  • 10.3.4 UAE Mycalolide B Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 Mycalolide B Market Drivers
• 11.2 Mycalolide B Market Restraints
• 11.3 Mycalolide B Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Mycalolide B Industry Chain
• 12.2 Mycalolide B Upstream Analysis
• 12.3 Mycalolide B Midstream Analysis
• 12.4 Mycalolide B Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Mycalolide B market size was valued at US$ 0.46 million in 2025 and is forecast to a readjusted size of US$ 0.67 million by 2032 with a CAGR of 5.3% during review period.
Mycalolide B is a highly potent, micro-scale marine natural product research reagent with CAS No. 122752-21-0, molecular formula C52H74N4O17, and molecular weight of approximately 1027.16. It is commonly supplied as a white to off-white solid, clear film, lyophilized wax, or lyophilized solid and requires low-temperature, light-protected, dry storage. The product belongs to the category of marine macrolide toxins and cytoskeleton-modulating small molecules. It has a complex molecular architecture containing a macrolide framework, oxygen-rich structural motifs, and nitrogen-containing heterocyclic fragments. Commercial grades are generally supplied in microgram-scale packages with purity levels of 95% or 98% and above. Its functional principle is based on modulation of actin dynamics: it can sever filamentous actin, shift actin toward the monomeric state, and inhibit actomyosin ATPase-related activity. Because of its high potency, low dosage requirement, strong toxicity, and difficult preparation and purification profile, Mycalolide B is mainly used in life science research, cytoskeleton mechanism studies, tumor cell migration and invasion research, smooth muscle pharmacology, and marine natural product or analogue development. It is not intended for diagnostic, therapeutic, food, cosmetic, human, or veterinary use.
The market opportunity for Mycalolide B is primarily supported by cytoskeleton research, tumor invasion and metastasis studies, marine natural product pharmacology, and demand for highly active small-molecule tool compounds. As live-cell imaging, high-content screening, tumor microenvironment research, and lead-structure exploration continue to advance, specialized reagents capable of clearly modulating actin dynamics will remain relevant. The product has a high unit price and extremely low dosage requirement, making it suitable for a low-volume, high-value research reagent model. Its growth depends more on research projects, paper citations, analogue development, and institutional procurement than on industrial-scale consumption.
The main restraints are its very narrow user base, fragmented annual demand, low repeat-purchase frequency per laboratory, and high supply-chain requirements associated with natural sourcing, complex structure, purification, quality control, cold-chain storage, and safety compliance. The product is generally limited to research use and is not positioned for diagnostic, therapeutic, food, cosmetic, human, or veterinary applications. Although multiple supplier pages are searchable, stock availability, batch consistency, and upstream source transparency vary. Buyers usually need to verify the CAS number, purity, analytical data, and batch certificate before procurement. Including analogues or drug candidates in the same market would materially overstate the actual reagent market.
Downstream demand will remain concentrated in universities, research institutes, pharmacology laboratories, cancer research centers, biotechnology companies, and natural product chemistry groups. Incremental demand is expected from studies on cell migration, cell division, immune synapses, pathogen invasion, smooth muscle contraction, and cancer metastasis, as well as research into simplified analogues, side-chain fragments, and conjugated payloads derived from the parent structure. The prevailing purchasing format is expected to remain 20 microgram to 100 microgram packages, with limited custom synthesis or bulk inquiries from specialized projects. The product itself is unlikely to become a large-volume general-purpose raw material.
This report is a detailed and comprehensive analysis for global Mycalolide B market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mycalolide B market size and forecasts, in consumption value ($ Million), 2021-2032
Global Mycalolide B market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Mycalolide B market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Mycalolide B market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mycalolide B
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mycalolide B market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM Wako Pure Chemical, Enzo Life Sciences, Santa Cruz Biotechnology, Focus Biomolecules, Biorbyt, AG Scientific, Abbexa, GLP Bio, Aladdin Scientific, BOC Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Mycalolide B market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
≥95% HPLC Grade
≥98% HPLC Grade
NMR-Confirmed High-Purity Grade
Market segment by Package Size
20 µg Vial
100 µg Vial
Custom Micro-Scale Package
Market segment by Delivery Form
Lyophilized Solid
Lyophilized Wax
Clear-to-White Solid
Market segment by Application
Medical Care
Research
Others
Market segment by players, this report covers
FUJIFILM Wako Pure Chemical
Enzo Life Sciences
Santa Cruz Biotechnology
Focus Biomolecules
Biorbyt
AG Scientific
Abbexa
GLP Bio
Aladdin Scientific
BOC Sciences
Alfa Chemistry
G-Biosciences
Tribioscience
TargetMol
InvivoChem
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Mycalolide B product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Mycalolide B, with revenue, gross margin, and global market share of Mycalolide B from 2021 to 2026.
Chapter 3, the Mycalolide B competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Mycalolide B market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mycalolide B.
Chapter 13, to describe Mycalolide B research findings and conclusion.